CL2008000550A1 - Compuestos derivados de pirazol-3-carboxamida en forma amorfa; disolucion solida amorfa; procedimiento de preparacion de la disolucion solida amorfa; y composicion farmaceutica que la comprende. - Google Patents
Compuestos derivados de pirazol-3-carboxamida en forma amorfa; disolucion solida amorfa; procedimiento de preparacion de la disolucion solida amorfa; y composicion farmaceutica que la comprende.Info
- Publication number
- CL2008000550A1 CL2008000550A1 CL200800550A CL2008000550A CL2008000550A1 CL 2008000550 A1 CL2008000550 A1 CL 2008000550A1 CL 200800550 A CL200800550 A CL 200800550A CL 2008000550 A CL2008000550 A CL 2008000550A CL 2008000550 A1 CL2008000550 A1 CL 2008000550A1
- Authority
- CL
- Chile
- Prior art keywords
- amorfa
- solid dissolution
- carboxamida
- pirazol
- understands
- Prior art date
Links
- 238000004090 dissolution Methods 0.000 title 2
- 239000007787 solid Substances 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0701377A FR2913018A1 (fr) | 2007-02-23 | 2007-02-23 | Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008000550A1 true CL2008000550A1 (es) | 2008-07-04 |
Family
ID=38561793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200800550A CL2008000550A1 (es) | 2007-02-23 | 2008-02-22 | Compuestos derivados de pirazol-3-carboxamida en forma amorfa; disolucion solida amorfa; procedimiento de preparacion de la disolucion solida amorfa; y composicion farmaceutica que la comprende. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20100076023A1 (es) |
| EP (1) | EP2132182A2 (es) |
| JP (1) | JP2010519246A (es) |
| KR (1) | KR20090113305A (es) |
| CN (1) | CN101641333A (es) |
| AR (1) | AR065410A1 (es) |
| AU (1) | AU2008240507A1 (es) |
| BR (1) | BRPI0807575A2 (es) |
| CA (1) | CA2678801A1 (es) |
| CL (1) | CL2008000550A1 (es) |
| CO (1) | CO6210812A2 (es) |
| EA (1) | EA200970792A1 (es) |
| FR (1) | FR2913018A1 (es) |
| IL (1) | IL200370A0 (es) |
| MA (1) | MA31244B1 (es) |
| MX (1) | MX2009008991A (es) |
| PE (1) | PE20081778A1 (es) |
| TW (1) | TW200846339A (es) |
| UY (1) | UY30937A1 (es) |
| WO (1) | WO2008129157A2 (es) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2761266B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates |
| FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| FR2873372B1 (fr) * | 2004-07-22 | 2006-09-08 | Sanofi Synthelabo | Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide |
| EP1844017A1 (en) * | 2005-01-06 | 2007-10-17 | Cadila Healthcare Ltd. | An amorphous and three crystalline forms of rimonabant hydrochloride |
| AR052660A1 (es) * | 2005-01-21 | 2007-03-28 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir la cdk's y gsk's |
| KR100678824B1 (ko) * | 2005-02-04 | 2007-02-05 | 한미약품 주식회사 | 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물 |
| DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
| EP1816125A1 (en) * | 2006-02-02 | 2007-08-08 | Ranbaxy Laboratories, Ltd. | Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof |
| WO2007103711A2 (en) * | 2006-03-01 | 2007-09-13 | Dr. Reddy's Laboratories Ltd. | Polymorphic forms of rimonabant |
| WO2008102367A1 (en) * | 2007-02-19 | 2008-08-28 | Darmesh Mahendrabhai Shah | Process for preparation of pyrazole derivatives |
-
2007
- 2007-02-23 FR FR0701377A patent/FR2913018A1/fr active Pending
-
2008
- 2008-02-20 CN CN200880009562A patent/CN101641333A/zh active Pending
- 2008-02-20 PE PE2008000359A patent/PE20081778A1/es not_active Application Discontinuation
- 2008-02-20 JP JP2009550302A patent/JP2010519246A/ja active Pending
- 2008-02-20 KR KR1020097017532A patent/KR20090113305A/ko not_active Application Discontinuation
- 2008-02-20 CA CA002678801A patent/CA2678801A1/fr not_active Abandoned
- 2008-02-20 EA EA200970792A patent/EA200970792A1/ru unknown
- 2008-02-20 MX MX2009008991A patent/MX2009008991A/es not_active Application Discontinuation
- 2008-02-20 EP EP08775573A patent/EP2132182A2/fr not_active Withdrawn
- 2008-02-20 BR BRPI0807575-1A patent/BRPI0807575A2/pt not_active IP Right Cessation
- 2008-02-20 AU AU2008240507A patent/AU2008240507A1/en not_active Abandoned
- 2008-02-20 WO PCT/FR2008/000216 patent/WO2008129157A2/fr active Application Filing
- 2008-02-21 AR ARP080100705A patent/AR065410A1/es unknown
- 2008-02-21 TW TW097106126A patent/TW200846339A/zh unknown
- 2008-02-22 CL CL200800550A patent/CL2008000550A1/es unknown
- 2008-02-22 UY UY30937A patent/UY30937A1/es not_active Application Discontinuation
-
2009
- 2009-08-12 IL IL200370A patent/IL200370A0/en unknown
- 2009-08-19 US US12/543,942 patent/US20100076023A1/en not_active Abandoned
- 2009-08-19 CO CO09087002A patent/CO6210812A2/es unknown
- 2009-09-10 MA MA32210A patent/MA31244B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200846339A (en) | 2008-12-01 |
| CO6210812A2 (es) | 2010-10-20 |
| PE20081778A1 (es) | 2009-01-01 |
| BRPI0807575A2 (pt) | 2014-07-01 |
| IL200370A0 (en) | 2010-04-29 |
| AR065410A1 (es) | 2009-06-03 |
| WO2008129157A2 (fr) | 2008-10-30 |
| EP2132182A2 (fr) | 2009-12-16 |
| MX2009008991A (es) | 2009-09-03 |
| WO2008129157A4 (fr) | 2009-03-05 |
| MA31244B1 (fr) | 2010-03-01 |
| JP2010519246A (ja) | 2010-06-03 |
| AU2008240507A1 (en) | 2008-10-30 |
| UY30937A1 (es) | 2008-09-30 |
| CN101641333A (zh) | 2010-02-03 |
| US20100076023A1 (en) | 2010-03-25 |
| WO2008129157A3 (fr) | 2008-12-31 |
| KR20090113305A (ko) | 2009-10-29 |
| CA2678801A1 (fr) | 2008-10-30 |
| EA200970792A1 (ru) | 2010-04-30 |
| FR2913018A1 (fr) | 2008-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
| CL2007002916A1 (es) | Compuestos derivados de pirazoliltienopiridinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en la inhibicion de escaras. | |
| DK2345410T3 (da) | Farmaceutisk sammensætning til modificeret frigivelse | |
| DK2068822T4 (da) | Selvpræserverede vandige farmaceutiske sammensætninger | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| DK2068839T3 (da) | Farmaceutiske sammensætninger omfattende nilotinib eller salt deraf | |
| BRPI0820665A2 (pt) | compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos | |
| BRPI0909030A2 (pt) | composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. | |
| DK2046264T3 (da) | Fremgangsmåder til fremstillingen af sammensætninger med film | |
| BRPI0819218A2 (pt) | Métodos, estojos e composições para administração de compostos farmacêuticos | |
| BRPI0908596A2 (pt) | formulação e composição farmacêutica de liberação prolongada | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0908132A2 (pt) | Composto de benzodiazepina e composição farmacêutica | |
| CL2007001630A1 (es) | Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
| DK2216021T3 (da) | Farmaceutisk sammensætning til behandling af overaktiv blære |